Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
83.85
+0.12 (0.14%)
Jul 27, 2026, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Product Net Revenue
5.42M-
Collaboration and License Revenue
2.28M1.04M
Revenue (Total)
7.70M1.04M